Home › Small Cell Lung Cancer › NCT04342429

Prospective Study of Intensity-Modulated Proton Therapy (IMPT) for Small Cell Lung Cancer

RAD4649-19: Prospective Study of Intensity-Modulated Proton Therapy (IMPT) for Small Cell Lung Cancer

Who can join

Ages 18 and older · All sexes · Healthy volunteers welcome

Inclusion Criteria:

* Pathologically confirmed small cell lung cancer, limited or extensive stage.
* Patients who are offered thoracic radiotherapy with intensity-modulated proton therapy (IMPT) techniques delivering 30-66 Gy in 15-33 fractions at 2 Gy per fraction, at the recommendation of the treating radiation oncologist.
* Age 18 or greater

Exclusion Criteria:

* Prior radiation therapy which would provide significant dose overlap with the planned target volume(s)
* Pregnancy

About the study

To assess the safety and efficacy of intensity-modulated proton therapy (IMPT) for small cell lung cancer (SCLC)

What is being tested

• Proton-beam Therapy for Small Cell Lung Cancer (radiation)

Sponsor: Emory University · Participants: 30 · Started: Mar 19, 2020

Contact the study team

• Kristin Higgins, MD · Phone: 404-778-0603
• Allyson Anderson · Phone: 404-251-2854

Official record on ClinicalTrials.gov — NCT04342429

Locations in the U.S.

Conditions

• Small Cell Lung Cancer

From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.